Detailed Information
Cited 5 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Alectinib (ALC) vs crizotinib (CRZ) in treatment-naive ALK plus non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study
- Authors
- Mok, TSK[Mok, T. S. K.]; Peters, S[Peters, S.]; Camidge, DR[Camidge, D. R.]; Ou, SHI[Ou, S-H I.]; Ahn, JS[Ahn, J. S.]; Tan, EH[Tan, E. H.]; Li, Z[Li, Z.]; Lee, JS[Lee, J-S.]; Cho, BC[Cho, B. C.]; Geater, SL[Geater, S. L.]; Sriuranpong, V[Sriuranpong, V.]; Ho, J[Ho, J.]; Chan, OSH[Chan, O. S-H]; Zeaiter, A[Zeaiter, A.]; Balas, B[Balas, B.]; Nueesch, E[Nueesch, E.]; Mitry, E[Mitry, E.]; Morcos, PN[Morcos, P. N.]; Kim, DW[Kim, D-W.]
- Issue Date
- Nov-2017
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.28, pp.191 - 191
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 28
- Start Page
- 191
- End Page
- 191
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.